Question 1

What is the Wagner-Nelson method and how does it estimate the absorption rate constant?

Accepted Answer

The Wagner-Nelson method estimates the absorption rate constant (ka) for drugs administered without assuming zero- or first-order absorption. It derives ka from the slope of a semilog plot of percent drug unabsorbed versus time, using a mass balance equation. However, it applies only to drugs with one-compartment kinetics and requires knowing the elimination rate constant from post-intravenous administration data.

Question 2

How does the Loo-Riegelman method differ from the Wagner-Nelson method?

Accepted Answer

The Loo-Riegelman method estimates ka by comparing plasma concentration-time profiles post-administration using deconvolution methods, providing more comprehensive data than the Wagner-Nelson method. Unlike Wagner-Nelson, it works with drugs exhibiting multicompartment characteristics and offers insight into relative bioavailability and absorption characteristics. Both methods share limitations regarding intrasubject variability between administration routes.

Question 3

What are the main limitations of the Wagner-Nelson method?

Accepted Answer

The Wagner-Nelson method is complex and limited to drugs with one-compartment kinetics. It requires prior knowledge of the elimination rate constant from intravenous administration data. Additionally, it is affected by factors like gastrointestinal motility and enzymatic degradation, and shows intrasubject variability between different administration routes.

Question 4

What data requirements does the Loo-Riegelman method have?

Accepted Answer

The Loo-Riegelman method requires concentration versus time data for both oral and intravenous drug administration of the same subject. It assumes that drug distribution and elimination kinetics remain constant between doses. This dual-route data collection allows the method to characterize absorption profiles and relative bioavailability more comprehensively than single-route approaches.

Question 5

Why is the elimination rate constant important for the Wagner-Nelson method?

Accepted Answer

The elimination rate constant must be known beforehand for the Wagner-Nelson method to function, as it is derived from post-intravenous administration data. This parameter is essential for the mass balance equation underlying the method. Without accurate elimination rate constant values, the Wagner-Nelson method cannot reliably estimate the absorption rate constant from oral or other extravascular administration data.

Question 6

What is deconvolution and how does it apply to the Loo-Riegelman method?

Accepted Answer

Deconvolution is a mathematical technique used by the Loo-Riegelman method to separate absorption from elimination by comparing plasma concentration-time profiles following different administration routes. This approach allows researchers to understand relative bioavailability and absorption characteristics without the restrictive one-compartment assumption required by the Wagner-Nelson method.

Question 7

When should you choose the Loo-Riegelman method over the Wagner-Nelson method?

Accepted Answer

Choose the Loo-Riegelman method when studying drugs with multicompartment characteristics or when comprehensive absorption data is needed. It is also preferable when you have concentration-time data from both oral and intravenous administration routes available. The Wagner-Nelson method remains suitable only for simple one-compartment systems where elimination rate constant is already known.

Jednokompartmentowy model otwarty: Metoda Wagnera-Nelsona i Loo-Riegelmana do szacowania k_a

Browse More Videos